Clinical Trials · NCT07796477
A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Enrollment
- 240
- Start date
- Nov 2026
- Locations
- 1 site, China
- Primary endpoint
- Change from baseline in Hemoglobin A1c (HbA1c)